The effect of probiotic and synbiotic supplementation on lipid parameters among patients with cardiometabolic risk factors: a systematic review and meta-analysis of clinical trials
Cardiovascular Research · 02.05.2023 · 119 (4) · 933-956
DOI: 10.1093/cvr/cvac128 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Cardiovascular Research, online erschienen am 08.08.2022. Verfasst von Zeinab Ghorbani und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Diseases Research Center, Department of Cardiology, Heshmat Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht…. Hauptthemen laut MEDLINE: Synbiotics, Probiotics, Cardiovascular Diseases. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 97 Literaturangaben.
Abstract (Originalsprache)
Although the available evidence emphasizes the beneficial effects of probiotics in normalizing various cardiometabolic markers, there is still substantial uncertainty in this regard. Thus, we set out to determine the effect sizes of probiotics on blood lipid parameters more coherently. A systematic literature search of the Medline (PubMed) and Scopus databases was conducted from inception to 12 February 2021, applying both MeSH terms and free text terms to find the relevant randomized controlled trials (RCTs). The meta-analysis was conducted based on a random-effect model to calculate the mean effect sizes demonstrated as weighted mean differences (WMDs) and the 95% confidence intervals (95% CIs). To explore the heterogeneity, the Cochrane χ2 test, and analysis of Galbraith plots were performed. Meta-analysis of data from 40 RCTs (n = 2795) indicated a significant decrease in serum/plasma triglyceride [WMD (95% CI) = –12.26 (–17.11 to –7.41) mg/dL; P-value <0.001; I2 (%) = 29.9; P heterogeneity = 0.034], total cholesterol (with high heterogeneity) (WMD (95% CI) = –8.43 (–11.90 to –4.95) mg/dL; P-value <0.001; I2 (%) = 56.8; P heterogeneity < 0.001), LDL-C [WMD (95% CI) = –5.08 (–7.61, –2.56) mg/dL; P-value <0.001; I2 (%) = 42.7; P heterogeneity = 0.002], and HDL-C (with high heterogeneity) (WMD (95% CI) = 1.14 (0.23, 2.05) mg/dL; P-value = 0.014; I2 (%) = 59.8; P heterogeneity < 0.001) following receiving probiotic/synbiotic supplements. Collectively, the current preliminary evidence supports the effectiveness of probiotics/synbiotics in improving dyslipidaemia and various lipid parameters more prominently among subjects with hyperlipidaemia, diabetes, and metabolic syndrome. However, large and well conducted RCTs are required to provide further convincing support for these results.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiovascular Diseases Research Center, Department of Cardiology, Heshmat Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
- Department of Clinical Nutrition, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
- Nutrition Research Center, School of Nutrition and Food Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
- Experimental and Clinical Research Center, A Cooperation of Charité-Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine, Lindenberger Weg 80, 13125, Berlin, Germany.
- Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125 Berlin, Germany.
- Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany.
ORCID-Profile: Zeinab Ghorbani, Asma Kazemi, Ulrike Löber, Sofia K Forslund
Zitieren
APA
Ghorbani, Z., Kazemi, A., U P Bartolomaeus, T., Martami, F., Noormohammadi, M., Salari, A., Löber, U., Balou, H. A., K Forslund, S., & Mahdavi-Roshan, M. (2023). The effect of probiotic and synbiotic supplementation on lipid parameters among patients with cardiometabolic risk factors: a systematic review and meta-analysis of clinical trials. Cardiovascular Research, 119(4), 933-956. https://doi.org/10.1093/cvr/cvac128
Vancouver
Ghorbani Z, Kazemi A, U P Bartolomaeus T, Martami F, Noormohammadi M, Salari A, et al. The effect of probiotic and synbiotic supplementation on lipid parameters among patients with cardiometabolic risk factors: a systematic review and meta-analysis of clinical trials. Cardiovascular Research. 2023;119(4):933-956. doi:10.1093/cvr/cvac128
BibTeX
@article{Ghorbani2023,
author = {Ghorbani, Zeinab and Kazemi, Asma and U P Bartolomaeus, Theda and Martami, Fahimeh and Noormohammadi, Morvarid and Salari, Arsalan and Löber, Ulrike and Balou, Heydar Ali and K Forslund, Sofia and Mahdavi-Roshan, Marjan},
title = {The effect of probiotic and synbiotic supplementation on lipid parameters among patients with cardiometabolic risk factors: a systematic review and meta-analysis of clinical trials},
journal = {Cardiovascular Research},
year = {2023},
volume = {119},
number = {4},
pages = {933--956},
doi = {10.1093/cvr/cvac128}
}
EUVIMED